Home
Mintz
Joanne S. Hawana
Joanne S. Hawana
Mintz
Connecticut Law Imposes New Requirements On Pharmaceutical Manufacturers, Defined To Include Device And Cosmetic Manufacturers, That Employ "Pharmaceutical Sales Representatives"
14 Nov 2023 | United States
Guidance From FDA Clarifies A Key Issue For Industry: Non-Promotional Presentations About Unapproved Uses Of Medical Products Can Be Produced By The Products' Sponsors Without Violating Off-Label Rules
01 Nov 2023 | United States
Five Topline Takeaways From FDA's Proposed Rulemaking On Lab-Developed Tests
03 Oct 2023 | United States
FDA Warns "Natural" Birth Control Company: Three Takeaways From The NOV Letter
03 Aug 2023 | United States
First Nonprescription Birth Control Pill Approved For Marketing By FDA: A Milestone For Reproductive Health
27 Jul 2023 | United States
Those Aren't Doritos: FTC And FDA Send Warning Letters To Companies Marketing Delta-8 Infused Munchies
20 Jul 2023 | United States
Recent Developments Signal Headwinds For Homeopathic Drug Products
30 Jun 2023 | United States
Moving Towards MOCRA Implementation: FDA Announces Industry "Listening Session"
12 May 2023 | United States
FTC Sends Notice Of Potential Penalties To Approximately 670 Companies Regarding Substantiation Of Advertising Claims
28 Apr 2023 | United States
Medical Device Developers Now Required To Incorporate Cybersecurity Plans Into FDA Premarket Submissions For "Cyber" Devices
13 Apr 2023 | United States
FDA Modernizes Mammography Regulations, Provides Facilities With Eighteen-Month Compliance Deadline
29 Mar 2023 | United States
FDA's Holiday Present From Congress: Bipartisan Reforms To The Accelerated Approval Framework, Long-Awaited Cosmetic Modernization, And Expansion Of Certain Existing Programs
12 Jan 2023 | United States
Cosmetic Regulatory Reform Finally Becomes Law
04 Jan 2023 | United States
Regulatory Roundup: Important FDA Developments At The End Of September 2022
11 Oct 2022 | United States
FDA Is Accepting EUA Requests For Monkeypox Tests, But Time Is Of The Essence
28 Sep 2022 | United States
Pharmaceutical Manufacturer Pays $7.9 Million To Resolve Allegations That It Caused The Submission Of Over-the-Counter Drugs To Medicare Part D
21 Sep 2022 | United States
FDA Announces Review Of Opioid Prescribing Regulations And Framework For Preventing Overdose-Related Deaths
08 Sep 2022 | United States
Recent FDA Warning Letter To Amazon.com Suggests The Agency Is Getting Tired Of The Whack-a-Mole Game
23 Aug 2022 | United States
Will A Nonprescription Birth Control Pill Be FDA's First Approval Under Its Long-Awaited "ANCU" Proposed Rule?
21 Jul 2022 | United States
Summer 2022 Is Here – Do You Know How The FDA User Fee Legislation Is Going?
03 Jun 2022 | United States
< 1 2 3 4 5 6 7 8 9 10 >
20%
Very Popular: This author falls within the Top 20% for the below topics and industry categories
Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States for the topics, user groups and industry sectors listed below*:
Topics
  • Life Sciences, Biotechnology & Nanotechnology
* Rankings are based on analysis of the last 12 months of Mondaq readership data across more than 25,000 contributing authors. To be ranked ‘Very Popular’ an author must be in the top 20% of results within the selected criteria.
Contact Details
Washington, DC
Email Website
One Financial Center
Washington, DC MA 02111
United States
Telephone: 1-617-5426000

  © Mondaq® Ltd 1994 - 2023. All Rights Reserved.